These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6967766)

  • 21. Antigenicity of passively acquired major histocompatibility antigens on T cells.
    Swartz TJ; Evavold B; Suzuki H; Yokoyama A; Quintans J
    Transplantation; 1988 Jul; 46(1):137-43. PubMed ID: 3260698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elicitation of anti-H-2 cytotoxic T lymphocytes with antigen-modified H-2 negative stimulator cells.
    Hale AH; Ruebush MJ; Harris DT; McGee MP
    J Immunol; 1981 Apr; 126(4):1485-8. PubMed ID: 6970778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccinia-specific cytotoxic T-cell responses in the context of H-2 antigens not encountered in thymus may reflect aberrant recognition of a virus-H-2 complex.
    Doherty PC; Bennink JC
    J Exp Med; 1979 Jan; 149(1):150-7. PubMed ID: 310857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloantigenic sites on class I major histocompatibility complex antigens: 61-69 region in the first domain of the H-2Kb molecule induces specific antibody and T cell responses.
    Singh B; Waters CA; Swanlund D
    J Immunol; 1986 Oct; 137(7):2311-8. PubMed ID: 2428867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic factors in the stimulation of T cell responses against ectromelia virus-infected cells: role of H-2K, H-2D, and H-2I genes.
    Pang T; Blanden RV
    Aust J Exp Biol Med Sci; 1977 Oct; 55(5):549-59. PubMed ID: 203261
    [No Abstract]   [Full Text] [Related]  

  • 26. A novel type of T-T cell interaction removes the requirement for I-B region in the H-2 complex.
    Baxevanis CN; Nagy ZA; Klein J
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3809-13. PubMed ID: 6791162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiments and speculation on antiviral specificity of T and B cells.
    Zinkernagel RM; Rosenthal KL
    Immunol Rev; 1981; 58():131-55. PubMed ID: 6171502
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity.
    Blank KJ; Lilly F
    Nature; 1977 Oct; 269(5631):808-9. PubMed ID: 73137
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternative pathways of T lymphocyte activation.
    Bach FH; Alter BJ
    J Exp Med; 1978 Sep; 148(3):829-34. PubMed ID: 100571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The I-J puzzle.
    Murphy DB
    Annu Rev Immunol; 1987; 5():405-27. PubMed ID: 2954565
    [No Abstract]   [Full Text] [Related]  

  • 31. Recognition of conformational determinants on H-2 by cytolytic T lymphocytes.
    Sherman LA
    Nature; 1982 Jun; 297(5866):511-3. PubMed ID: 6178030
    [No Abstract]   [Full Text] [Related]  

  • 32. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
    Muraoka S
    Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivity of xenogeneic antihuman Ia antisera with the I-C subregion of the murine major histocompatibility complex. I. Genetic studies.
    Sandrin MS; McKenzie IF; Parish CR
    Transplantation; 1981 Jun; 31(6):465-70. PubMed ID: 6942556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells.
    Kruisbeek AM; Fultz MJ; Sharrow SO; Singer A; Mond JJ
    J Exp Med; 1983 Jun; 157(6):1932-46. PubMed ID: 6222135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different D end-dependent antigenic determinants are recognized by H-2-restricted cytotoxic T cells specific for influenza and Bebaru viruses.
    Blanden RV; Müllbacher A; Ashman RB
    J Exp Med; 1979 Jul; 150(1):166-3. PubMed ID: 87489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus-immune cytotoxic T-cell activity following negative selection of alloreactive precursor lymphocytes.
    Bennink JR; Doherty PC
    Transplant Proc; 1980 Mar; 12(1):172-4. PubMed ID: 6966098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.
    Schwartz RH
    Annu Rev Immunol; 1985; 3():237-61. PubMed ID: 2415139
    [No Abstract]   [Full Text] [Related]  

  • 39. Reciprocal stimulation of negatively selected high-responder and low-responder T cells in virus-infected recipients.
    Bennink JR; Doherty PC
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3482-5. PubMed ID: 115003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between H-2 and vaccinia virus-induced antigens on the surface of infected cells.
    Senik A; Neauport-Sautes C
    J Immunol; 1979 Apr; 122(4):1461-7. PubMed ID: 448095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.